Skip to content
Boost Up Blog – Lifestyle
Author:
Elixir Medical Corporation
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
August 19, 2026
Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
August 17, 2026
Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology
May 22, 2026
EuroPCR 2026: Elixir Medical’s DynamX® Bioadaptor Demonstrates Significantly Lower Event Rates Than Drug-Eluting Stent
May 21, 2026